pharma news today obesity drugs glp-1 october 2025 Market Overview: Agonists and the Market | Blog Obesity GLP-1 Market Size to

Tirzepatide: This is the active ingredient in Mounjaro and Zepbound

[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Kim W., Barhoumi R., McMurray D.N., Chapkin R.S

doi: 10.1016/S0140-6736(87)91194-9 92 SharmaDVermaSVaidyaSKaliaKTiwariV

Importantly, while weight loss represents a major contributor to the clinical benefits of GLP-1RAs, accumulating evidence indicates that these agents also exert non-weight-dependent effects

10.18632/aging.102899 145 XiongX.-Q.GengZ.ZhouB.ZhangF.HanY.ZhouY.-B.et al (2018)

The isoconversional method allows for the analysis of the scanning rate dependency of the melting properties